No Impact of Disease Duration on Response to Tildrakizumab Treatment Among Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses from Two Phase 3 (Resurface 1 and Resurface 2) and One Phase 4 (Tribute) Studies

No Impact of Disease Duration on Response to Tildrakizumab Treatment Among Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses from Two Phase 3 (Resurface 1 and Resurface 2) and One Phase 4 (Tribute) Studies

In the literature there is no consensus on the correlation between early systemic intervention and better treatment response in psoriasis. Here we present data on the impact of disease duration (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Skin health and disease 2023-10, Vol.3 (5), p.e263-e263
Hauptverfasser: Griss, Johannes, Ratzinger, Gudrun, Maul, Julia-Tatjana, Weger, Wolfgang, Thaçi, Diamant, Carrascosa, José Manuel, Jonak, Constanze
Format: Artikel
Sprache:eng
Schlagworte:
Advisors
Clinical medicine
Clinical trials
Cytokines
Editing
Psoriasis
Research Letter
Research Letters
Writing
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In the literature there is no consensus on the correlation between early systemic intervention and better treatment response in psoriasis. Here we present data on the impact of disease duration (
ISSN:2690-442X
2690-442X
DOI:10.1002/ski2.263